MedPath

Guided bone regeneration of peri-implant defects with particulate versus soft-type block bone substitutes. A randomized controlled, single blinded clinical trial

Phase 4
Recruiting
Conditions
K00-K14
Diseases of oral cavity, salivary glands and jaws
Registration Number
DRKS00020222
Lead Sponsor
Clinic of Reconstructive DentistryCenter of Dental MedicineUniversity of Zürich
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
64
Inclusion Criteria

Patients, in need of at least one implant with an expected peri-implant bone dehiscence = 2 mm of apico-coronal dimension in the maxilla or mandible (excl. molars)
-primary implant stability assessed at implant placement
-no need of soft tissue grafting after implant placement
-tooth extraction performed = 4 months in advance
-possibly performed soft tissue grafting = 2 months in advance
-Presence of one adjacent tooth at the implant site;
-Presence of antagonist;
-Adequate oral hygiene (Bleeding on probing <20%; Plaque index <20%);
-Capability to comply with the study procedures
-Signed Informed Consent Form

Exclusion Criteria

-Ridge preservation procedure after tooth extraction performed
-Pregnant or lactating women;
-Known or suspected non-compliance, drug or alcohol abuse
-Smokers (>10 cigarettes/day including e-cigarettes)
-Currently taking drugs that influence bone metabolism
-Use of bisphosphonates in the last 4 years
-Systemic or local conditions presenting a contraindication to implant treatment
-History of malignancy, radiotherapy or chemotherapy for malignancy in the past 5 years

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of horizontal bone thickness at the level of the implant shoulder of the augmented region between baseline (implant placement) and 6 months visit, measured by CBCT
Secondary Outcome Measures
NameTimeMethod
-marginal bone level (implant shoulder to first bone-to-implant-contact) at baseline, 6 months, 1 year, 3 and 5 years, by radiographs<br><br>- Implant survival at 6 months, 1 year, 3 and 5 years by visual observation<br><br>- horizontal bone thickness at the level of the implant shoulder of the augmented area at 6 months, 1 year, 3 and 5 years by CBCT<br><br>- vertical defect fill at implant placement, at 6 months and at 5 years by radiographs<br><br>- soft tissue volume at the area of interest at implant placement, at 6 months, 1 years, 3 and 5 years by volumetric analysis of the digital impressions<br><br>- PD, REC and KT, PI, BOP, MML at Baseline, 6 months, 1 year, 3 and 5 years) by probing<br><br>- PES: evaluator rating at final reconstruction, 1 year, 3 and 5 years<br> <br>-Patient reported outcomes (OHIP questionnaire, general rating of outcome) at 6 months, final reconstruction, 1 year,3 and 5 years<br><br>-Prosthetic outcomes by USPHS
© Copyright 2025. All Rights Reserved by MedPath